Amblyopia treatment outcomes in patients with neurodevelopmental disorders.

ABSTRACT:

Purpose

To compare amblyopia treatment outcomes between patients with neurodevelopmental disorders and their typically developing peers.

Methods

Of 2,311 patients diagnosed with amblyopia between 2010 and 2014 at Boston Children's Hospital, 460 met inclusion criteria (age 2-12 with anisometropic, strabismic, or mixed amblyopia [interocular difference (IOD) ≥2 lines]). Treatment and visual outcomes were analyzed according to neurodevelopmental status: neurodevelopmental delay (DD) versus typical development (TD).

Results

The DD group (n = 54) and TD group (n = 406) were similar in demographics, amblyogenic risk factors, baseline visual measures, prescribed therapy, and adherence (P ≥ 0.10). Between-visit follow-up time was longer for the DD group (0.65 [0.42- 0.97] yea

SUBMITTER: Chinn RN 

PROVIDER: S-EPMC10591796 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature